January 31, 2024 Comments Off on New patent for Amneal drug LYVISPAH Posted in: Patent Added Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent for Amneal drug LYVISPAH appeared first on DrugPat…
January 31, 2024 Comments Off on New patent for Seagen drug TUKYSA Posted in: Patent Added Annual Drug Patent Expirations for TUKYSA Tukysa is a drug marketed by Seagen and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Seagen drug TUKYSA appeared first on DrugPatentWatch …